ATE248603T1 - Reinigungsverfahren für von bordetella produziertem nekrotoxin - Google Patents

Reinigungsverfahren für von bordetella produziertem nekrotoxin

Info

Publication number
ATE248603T1
ATE248603T1 AT95921113T AT95921113T ATE248603T1 AT E248603 T1 ATE248603 T1 AT E248603T1 AT 95921113 T AT95921113 T AT 95921113T AT 95921113 T AT95921113 T AT 95921113T AT E248603 T1 ATE248603 T1 AT E248603T1
Authority
AT
Austria
Prior art keywords
toxoid
dermonecrotic toxin
produced
bordetella
dermonecrotic
Prior art date
Application number
AT95921113T
Other languages
English (en)
Inventor
Toru Kawai
Toshihiro Ushijima
Kozo Takase
Hideo Fujikawa
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE248603T1 publication Critical patent/ATE248603T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95921113T 1994-06-10 1995-06-07 Reinigungsverfahren für von bordetella produziertem nekrotoxin ATE248603T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15283494 1994-06-10
PCT/JP1995/001125 WO1995034322A1 (en) 1994-06-10 1995-06-07 Method of purifying necrotoxin produced by bordetella and toxoid

Publications (1)

Publication Number Publication Date
ATE248603T1 true ATE248603T1 (de) 2003-09-15

Family

ID=15549157

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95921113T ATE248603T1 (de) 1994-06-10 1995-06-07 Reinigungsverfahren für von bordetella produziertem nekrotoxin
AT02028045T ATE432712T1 (de) 1994-06-10 1995-06-07 Kombinationsvakzine enthaltend toxoid des dermonecrotischen toxins von bordetella bronchiseptica

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02028045T ATE432712T1 (de) 1994-06-10 1995-06-07 Kombinationsvakzine enthaltend toxoid des dermonecrotischen toxins von bordetella bronchiseptica

Country Status (10)

Country Link
US (1) US6124432A (de)
EP (2) EP1297845B1 (de)
JP (2) JP3884066B2 (de)
CN (2) CN1279978C (de)
AT (2) ATE248603T1 (de)
CA (1) CA2192165A1 (de)
DE (2) DE69531690T2 (de)
DK (2) DK0773030T3 (de)
ES (2) ES2206507T3 (de)
WO (1) WO1995034322A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine
CN103153337A (zh) 2010-09-28 2013-06-12 共立制药股份有限公司 黏膜佐剂组合物
IT201600076743A1 (it) * 2016-07-21 2018-01-21 St Superiore Di Sanita Nuovo uso del cnf1
CN107338208B (zh) * 2017-08-17 2020-07-28 天康生物股份有限公司 一种猪萎缩性鼻炎d型产毒多杀巴斯德氏菌疫苗株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
DE69131525T2 (de) * 1990-06-13 1999-11-25 Pfizer Inc., New York Pasteurella multocida toxoid enthaltende impfstoffe

Also Published As

Publication number Publication date
US6124432A (en) 2000-09-26
JP2006342175A (ja) 2006-12-21
DE69535964D1 (de) 2009-07-16
DE69531690T2 (de) 2004-07-08
CN1130225C (zh) 2003-12-10
ES2326793T3 (es) 2009-10-20
CN1279978C (zh) 2006-10-18
JP4340672B2 (ja) 2009-10-07
DK1297845T3 (da) 2009-07-13
EP0773030A1 (de) 1997-05-14
JP3884066B2 (ja) 2007-02-21
WO1995034322A1 (en) 1995-12-21
CN1154655A (zh) 1997-07-16
EP0773030B8 (de) 2004-01-14
CA2192165A1 (en) 1995-12-21
EP0773030B1 (de) 2003-09-03
ES2206507T3 (es) 2004-05-16
DE69531690D1 (de) 2003-10-09
EP1297845A2 (de) 2003-04-02
EP1297845A3 (de) 2003-04-16
DK0773030T3 (da) 2003-12-22
EP1297845B1 (de) 2009-06-03
EP0773030A4 (de) 1997-12-10
CN1494922A (zh) 2004-05-12
ATE432712T1 (de) 2009-06-15

Similar Documents

Publication Publication Date Title
ATE249244T1 (de) Aktivierte verbindungen und verfahren zur herstellung und reiningung
ATE44238T1 (de) Vakzine fuer gramnegative bakterien und verfahren zur herstellung derselben.
ATE69310T1 (de) Verfahren zur herstellung eines materials zur affinitaetschromatographie.
ATE83801T1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
DK0391526T3 (da) Antistofoprensningsfremgangsmåde
DK530587D0 (da) Fremgangsmaade til oprensning af toxinkonjugater
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
KR970021093A (ko) 인자 ⅶ 및 활성화된 인자 ⅶ의 정제 방법
ATE248603T1 (de) Reinigungsverfahren für von bordetella produziertem nekrotoxin
EP0385118A3 (de) Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen
ATE2090T1 (de) Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel.
DK0680765T3 (da) Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme
DE69711765D1 (de) Phrothrombin und Thrombin bindende Peptide.
FR2422699A1 (fr) Procede de preparation d'un materiau solide poreux revetu de cellulose ou de cellulose modifiee
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
US4845036A (en) Process for isolation of the B oligomer of pertussis toxin
GR3006766T3 (de)
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
ES2062513T3 (es) Metodo para purificar estreptoquinasas.
JPS57140726A (en) Purification of physiologically active substance having carcinostatic action
AU603794B2 (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus
FR2104732A1 (en) Asparaginase purification using asparagine in - hibitors coupled to carbohydrate matrix
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties